Showing results (11-20 of 52) with videos related to
Sort By:
Pageof 6
Frontiers in Pharmacology|January 24, 2020
Type 2β Corticotrophin Releasing Factor Receptor Forms a Heteromeric Complex With Dopamine D1 Receptor in Living CellsHector E Yarur, Maria Estela Andrés, Katia GyslingMolecular Pharmacology|September 27, 2022
Transcriptional Regulation, Signaling Pathways, and Subcellular Localization of Corticotropin-Releasing Factor Receptors in the Central Nervous SystemPaula Amado, Juan Zegers, Hector E Yarur, et al.Neuroreport|November 22, 2016
The activation of metabotropic glutamate 5 receptors in the rat ventral tegmental area increases dopamine extracellular levelsCarla Ferrada, Ramón Sotomayor-Zárate, Jorge Abarca, et al.Brain Research|October 1, 2016
Opposite effects of acute and chronic amphetamine on Nurr1 and NF-κB p65 in the rat ventral tegmental areaCristian Arredondo, Marcela González, María Estela Andrés, et al.Nucleic Acids Research|August 16, 2014
A comprehensive survey of non-canonical splice sites in the human transcriptomeGuillermo E Parada, Roberto Munita, Cledi A Cerda, et al.Journal of Neuroscience Research|May 6, 2006
Repeated administration of the selective kappa-opioid receptor agonist U-69593 increases stimulated dopamine extracellular levels in the rat nucleus accumbensJosé Antonio Fuentealba, Katia Gysling, Karin Magendzo, et al.Brain Research. Brain Research Reviews|December 2, 2004
Corticotropin-releasing hormone and urocortin: redundant or distinctive functions?Katia Gysling, María Inés Forray, Paola Haeger, et al.Plos One|March 26, 2013
An amphipathic alpha-helix in the prodomain of cocaine and amphetamine regulated transcript peptide precursor serves as its sorting signal to the regulated secretory pathwayElías H Blanco, Carlos F Lagos, María Estela Andrés, et al.Journal of Neuroscience Research|April 23, 2014
Withdrawal from chronic amphetamine reduces dopamine transmission in the rat lateral septumGeorgina M Renard, Ramón Sotomayor-Zarate, Elías H Blanco, et al.Behavioural Brain Research|February 19, 2017
Activation of type 4 dopaminergic receptors in the prelimbic area of medial prefrontal cortex is necessary for the expression of innate fear behaviorMacarena D Vergara, Victor N Keller, José A Fuentealba, et al.Pageof 6